COMPASS Pathways plc (CMPS)

NASDAQ

$7.05

+$0.10 (1.44%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$6.81$7.13

Open $7.02

52 Week Range

$2.25$8.90

Previous Close $6.95

Market Cap676.81M

Volume1.92M

Avg Volume2.58M

P/E (TTM)-2.77

EPS (TTM)$-2.49

Dividend / YieldN/A

Dividend StreakN/A

About COMPASS Pathways plc

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Company Info

SectorHealthcare

IndustryMedical - Care Facilities

CEOKabir Kumar Nath

Employees166

Websitecompasspathways.com

Trading Information

Open

$7.02

Previous Close

$6.95

Day High

$7.13

Day Low

$6.81

52 Week High

$8.90

52 Week Low

$2.25